H&Q Life Sciences Investors Analysis
| Analyst Ratings |
|
Average Target Price
|
|
|
Average Rating
|
|
|
# Strong Buys
|
|
|
# Buys
|
|
|
# Holds
|
|
|
# Sells
|
|
|
# Strong Sells
|
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
0.00
|
-1.08
|
-1.08
|
0.00%
|
|
2022-03-31
|
0.00
|
-3.03
|
-3.03
|
0.00%
|
|
2021-09-30
|
0.00
|
1.32
|
1.32
|
0.00%
|
|
2021-06-30
|
0.00
|
0.67
|
0.67
|
0.00%
|
|
2021-03-31
|
0.00
|
1.30
|
1.30
|
0.00%
|
|
2020-12-31
|
0.00
|
0.65
|
0.65
|
0.00%
|
|
2020-09-30
|
0.00
|
3.83
|
3.83
|
0.00%
|
|
2020-06-30
|
0.00
|
1.94
|
1.94
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-09-30
|
-4.11
|
|
2021-09-30
|
3.94
|
|
2020-09-30
|
7.71
|
|
2019-09-30
|
-4.59
|
|
2018-09-30
|
1.85
|
|
2017-09-30
|
4.77
|
|
2016-09-30
|
-1.09
|
|
2015-09-30
|
-1.93
|
|
2014-09-30
|
6.35
|
|
2013-09-30
|
5.96
|
|
2012-09-30
|
4.42
|
|
2011-09-30
|
2.51
|
|
2010-09-30
|
0.97
|